Difference between revisions of "Template:Cell wall disruptive antibiotics"
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
|group1 = Intracellular | |group1 = Intracellular | ||
|list1 = | |list1 = | ||
| − | * | + | * inhibit [[peptidoglycan]] subunit synthesis and transport: [[N-Acetylmuramic acid|NAM]] synthesis inhibition'' ([[Fosfomycin]]) |
| − | * | + | * [[D-alanine-D-alanine ligase|DADAL]]/[[alanine racemase|AR]] inhibitors ([[Cycloserine]]) |
| − | * | + | * [[bactoprenol]] inhibitors ([[Bacitracin]]) |
| group2 = [[Glycopeptide antibiotic|Glycopeptide]] | | group2 = [[Glycopeptide antibiotic|Glycopeptide]] | ||
| list2 = | | list2 = | ||
| − | * | + | * inhibit [[Peptidoglycan glycosyltransferase|PG]] chain elongation: [[Vancomycin]]<sup>#</sup> ([[Oritavancin]] |
* [[Telavancin]]) | * [[Telavancin]]) | ||
* [[Teicoplanin]] ([[Dalbavancin]]) | * [[Teicoplanin]] ([[Dalbavancin]]) | ||
| Line 30: | Line 30: | ||
| group1 = [[Extended-spectrum penicillin|Extended sp.]] | | group1 = [[Extended-spectrum penicillin|Extended sp.]] | ||
| list1 = | | list1 = | ||
| − | * | + | * [[aminopenicillin]]s: [[Amoxicillin]]<sup>#</sup> |
* [[Ampicillin]]<sup>#</sup> ([[Pivampicillin]] | * [[Ampicillin]]<sup>#</sup> ([[Pivampicillin]] | ||
* [[Hetacillin]] | * [[Hetacillin]] | ||
| Line 38: | Line 38: | ||
* [[Epicillin]] | * [[Epicillin]] | ||
| − | * | + | *[[carboxypenicillin]]s: [[Carbenicillin]] ([[Carindacillin]]) |
* [[Ticarcillin]] | * [[Ticarcillin]] | ||
* [[Temocillin]] | * [[Temocillin]] | ||
| Line 46: | Line 46: | ||
* [[Mezlocillin]] | * [[Mezlocillin]] | ||
| − | * | + | *other: [[Mecillinam]] ([[Pivmecillinam]]) |
* [[Sulbenicillin]] | * [[Sulbenicillin]] | ||
| Line 85: | Line 85: | ||
* [[Biapenem]] | * [[Biapenem]] | ||
* [[Ertapenem]] | * [[Ertapenem]] | ||
| − | * | + | * [[antipseudomonal]] ([[Doripenem]] |
* [[Imipenem]] | * [[Imipenem]] | ||
* [[Meropenem]]) | * [[Meropenem]]) | ||
| Line 125: | Line 125: | ||
* [[Cefuroxime]] | * [[Cefuroxime]] | ||
* [[Cefuzonam]] | * [[Cefuzonam]] | ||
| − | * | + | * [[cephamycin]] ([[Cefoxitin]] |
* [[Cefotetan]] | * [[Cefotetan]] | ||
* [[Cefmetazole]]) | * [[Cefmetazole]]) | ||
| − | * | + | * [[carbacephem]] ([[Loracarbef]]) |
| group3= [[Cephalosporin#Third_generation|3rd]] | | group3= [[Cephalosporin#Third_generation|3rd]] | ||
| Line 134: | Line 134: | ||
* [[Cefixime]]<sup>#</sup> | * [[Cefixime]]<sup>#</sup> | ||
* [[Ceftriaxone]]<sup>#</sup> | * [[Ceftriaxone]]<sup>#</sup> | ||
| − | * | + | * antipseudomonal ([[Ceftazidime]]<sup>#</sup> |
* [[Cefoperazone]]) | * [[Cefoperazone]]) | ||
* [[Cefcapene]] | * [[Cefcapene]] | ||
| Line 152: | Line 152: | ||
* [[Ceftiolene]] | * [[Ceftiolene]] | ||
* [[Ceftizoxime]] | * [[Ceftizoxime]] | ||
| − | * | + | * [[oxacephem]] ([[Flomoxef]] |
* [[Latamoxef]] <sup>‡</sup>) | * [[Latamoxef]] <sup>‡</sup>) | ||
| − | | group4= [[Cephalosporin#Fourth_generation|4th]] ( | + | | group4= [[Cephalosporin#Fourth_generation|4th]] (antipseudomonal) |
| list4= | | list4= | ||
* [[Cefepime]] | * [[Cefepime]] | ||
| Line 184: | Line 184: | ||
| group6 = [[β-Lactamase inhibitor|β-lactamase inh.]] | | group6 = [[β-Lactamase inhibitor|β-lactamase inh.]] | ||
| list6 = | | list6 = | ||
| − | * | + | * [[penam]] ([[Sulbactam]] |
* [[Tazobactam]]) | * [[Tazobactam]]) | ||
| − | * | + | * [[clavam]] ([[Clavulanic acid]]) |
| group7 = Combinations | | group7 = Combinations | ||
| Line 201: | Line 201: | ||
| group8 = Other | | group8 = Other | ||
| list8 = | | list8 = | ||
| − | * | + | * [[polymyxin]]s/[[detergent]] ([[Colistin]] |
* [[Polymyxin B]]) | * [[Polymyxin B]]) | ||
| − | * | + | * [[depolarizing]] ([[Daptomycin]]) |
| − | * | + | * hydrolyze NAM-NAG ([[lysozyme]]) |
* [[Gramicidin]] | * [[Gramicidin]] | ||
* [[Isoniazid]] | * [[Isoniazid]] | ||
Revision as of 17:20, 5 July 2014
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Cell wall disruptive antibiotics|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Cell wall disruptive antibiotics|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Cell wall disruptive antibiotics|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.